Searched for
IPCA SHARES
Vanguard slashes Ola value; War chokes PCB supplyAmerican investor Vanguard has sharply cut the fair value of Ola's parent company. This and more in today's ETtech Top 5.- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...
- Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a monthDespite a marginal rise in the Sensex, seven BSE 500 stocks touched fresh 52-week highs, signalling strong bullish momentum. Gland Pharma, ...
- Mutual funds cut technology sector exposure to 8-year low in April. Is AI disruption reshaping sentiment?Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
- Ipca Laboratorties promoter sells 1.6% stake for Rs 600 croreUsha Madhukar Chandurkar, one of the promoters of Ipca Laboratories, on Wednesday divested a 1.6 per cent stake in the pharmaceutical compa...
- Reduce Ipca Labs, target price Rs 1,250: Prabhudas LilladherIpca Labs (IPCA) Q1 EBITDA of Rs 3.9 bn was in line with our estimate. Management guidance of 9% revenue growth (excluding Unichem) was bel...
- Buy Ipca Laboratories, target price Rs 970: Nagaraj ShettiIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 23532.33 Crore) operating in Pharmaceutic...
- Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 crore"The Board approved entering into a definitive Share Purchase Agreement (SPA) for the acquisition of 2,35,01,440 fully paid-up equity share...
- Hold Ipca Laboratories, target price Rs 865: Prabhudas LilladherAt CMP, the stock is trading at 23x FY25E factoring in near term recovery.
- Big Movers on D-St: What should investors do with Apollo Hospitals, Adani Power and IPCA Laboratories?Stocks that were in focus on Thursday include names like Apollo Hospitals, Adani Power, and IPCA Laboratories.
- Ipca Labs acquires 13% stake in Trophic Wellness for Rs 21 croreThe acquisition of the shares is for cash consideration of Rs 21.20 crore for 5,30,000 equity shares of TWPL, Ipca Labs added.
- Ipca Labs Q3 results: Profit up 24% to Rs 197 croreTotal income also rose to Rs 1,230.99 crore for the quarter under consideration.
- IPCA Laboratories stock slumps 16 per centShares of IPCA Laboratories slumped nearly 16 per cent to hit its 52-week low in early trade amid reports of stock downgrade.
- Buy Ipca Laboratories Ltd with a target of Rs 885: Sandeep Wagle"Ipca Laboratories Ltd is a 'BUY' call with a target of Rs 885 and a stop loss of Rs 838."
- Ipca Labs offers to buy 30% of Tonira PharmaDrug maker Ipca Laboratories Ltd said on Monday it had made an open offer to buy 2.4 million shares of Tonira Pharma Ltd at Rs 29 each.
Load More
